Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115141) titled 'A real-world study on the influencing factors of the efficacy of ruxolitinib cream in the treatment of vitiligo' on Dec. 23, 2025.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Peking University Third Hospital
Condition:
Vitiligo
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-23
Target Sample Size: Ruxolitinib:170;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=291778
Published by HT Digital Content Services with permission from Health Daily Digest....